More MS news articles for May 2002

Biomedical Research Scientists Endorse Specter/Feinstein/Hatch/Kennedy Cloning Compromise

http://cbs.marketwatch.com/tools/quotes/newsarticle.asp?g=4F922163B0A7435D900DB42C247EC8C8&siteid=mktw&dist=mat

May 13, 2002, 4:04:00 PM
WASHINGTON,  /PRNewswire via COMTEX/

In a letter sent to Senator Arlen Specter on Friday, twenty-seven leading biomedical research scientists announced their strong support for S. 2439, the Human Cloning Prohibition Act of 2002 introduced by Senators Arlen Specter (R-PA), Dianne Feinstein (D-CA), Orrin Hatch (R-UT), and Edward Kennedy (D-MA). The scientists, who represent a wide variety of disciplines and academic institutions located throughout the United States, are board representatives of the Federation of American Societies for Experimental Biology (FASEB).

The scientists expressed their support for a ban on human reproductive cloning, but reaffirmed their support for research using nuclear transplantation to produce stem cells, a procedure sometimes referred to as "therapeutic cloning." In the letter, the scientists discussed the benefits of nuclear transplantation research over other human embryonic stem cell research.

The undersigned sent the following letter, dated May 7, to The Honorable Arlen Specter:

As board members of 21 scientific societies represented by the Federation of American Societies for Experimental Biology (FASEB), we are writing to thank you for introducing S. 2439, the Human Cloning Prohibition Act of 2002.

We strongly support your efforts to ban human reproductive cloning and to permit research involving nuclear transplantation to produce stem cells, under appropriate ethical guidelines.

We believe that human embryonic stem cell research offers significant therapeutic promise for treating a host of diseases and debilitating disorders afflicting millions of Americans. While we are grateful to the President for his decision last year to allow research on a qualified number of human embryonic stem cell lines, the usefulness of these cell lines is limited by a number of factors that can be addressed through nuclear transplantation. First, nuclear transplantation research will enable the production of embryonic stem cell lines that more fully represent the genetic diversity of the U.S. population. Second, nuclear transplantation will enable scientists to identify and understand the interplay of heritable genetic factors that gives rise to diseases such as diabetes or Alzheimer's. Third, in the field of cancer research, nuclear transplantation will enable scientists to examine a variety of mutations that produced certain cancer cells. Finally, nuclear transplantation research raises the hope that, in the future, patients will receive therapies that are individually developed for them -- dramatically reducing the risk of immune rejection.

For more than a half-century, America's best scientists have produced spectacular medical advances. The exciting new field of regenerative medicine now offers substantial potential for greater breakthroughs. S. 2439 would assure that this vital research is conducted under appropriate ethical guidelines -- and that Americans have early access to its therapeutic benefits.

Once again, on behalf of FASEB's 60,000 member scientists, we thank you for advancing biomedical research and strongly endorse S. 2439.

Robert R. Rich, MD
President, FASEB
American Association of Immunologists
Emory University School of Medicine
Atlanta, GA

Leo Furcht, MD
American Association of Investigative Pathology
University of Minnesota Medical School
Minneapolis, MN

Marlene Cohen, PhD
American Society for Pharmacology and Experimental Therapeutics
Lilly Research Laboratories
Indianapolis, IN

Richard G. Lynch, MD
American Society for Investigative Pathology
University of Iowa College of Medicine
Iowa City, IA

Barbara A. Horwitz, MD
The American Physiological Society
University of California - Davis
Davis, CA

Janet Hall, MD
The Endocrine Society
Massachusetts General Hospital, Harvard Medical School
Boston, MA

Gerald F. DiBona, MD
American Physiological Society
University of Iowa College of Medicine
Iowa City, IA

Michael Conn, PhD
The Endocrine Society
Oregon Health and Science University
Portland, OR

Karen L. Bennett
Society for Developmental Biology
University of Missouri
Columbia, MO

Richard Marchase, PhD
American Association of Anatomists
University of Alabama - Birmingham
Birmingham, AL

Robert D. Wells, PhD
American Society for Biochemistry & Molecular Biology
Texas A&M University
Houston, TX

Mary J.C. Hendrix, PhD
FASEB Past President
American Association of Anatomists
The University of Iowa
Iowa City, IA

Alfred H. Merrill, PhD
American Society for Nutritional Sciences
Georgia Institute of Technology
Atlanta, GA

James C. Rose, PhD
Society for Gynecologic Investigation
Wake Forest University
Winston Salem, NC

Roger A. Sunde, PhD
American Society for Nutritional Sciences
University of Missouri
Columbia, MO

Jerry Mitchell, MD, PhD
American Society for Pharmacology and Experimental Therapeutics
Baylor College of Medicine
Houston, TX

C. Robert Matthews, PhD
The Protein Society
University of Massachusetts Medical School
Worcester, MA

Garry Cutting, MD
The American Society for Human Genetics
Johns Hopkins University
Baltimore, MD

John A. Smith, MD, PhD
American Peptide Society
University of Alabama, Birmingham
Birmingham, AL

David Valle, MD
American Society for Human Genetics
Johns Hopkins University
Baltimore, MD

David G. Kaufman, MD, PhD
FASEB Past-President
University of North Carolina
Chapel Hill, NC

Robert D. Koos, PhD
Society for the Study of Reproduction
University of Maryland
Baltimore, MD

Michael A. Levine, MD
American Society for Bone & Mineral Research
Johns Hopkins University
Baltimore, MD

John M. DeSesso, PhD
Teratology Society
Mitretek Systems
Falls Church, VA

Paul W. Kincade, PhD
The American Association of Immunologists
Oklahoma Medical Research Foundation
Oklahoma City, OK

Steven Teitelbaum, MD
FASEB President-Elect
American Society for Bone & Mineral Research
Washington University School of Medicine
St. Louis, MO

Bettie Sue Masters, PhD
American Society for Biochemistry & Molecular Biology
University of Texas Health Science Center
San Antonio, TX

SOURCE
Federation of American Societies for Experimental Biology

CONTACT:
Pat White of the Federation of American Societies for Experimental Biology, +1-202-543-1155

URL:
http://www.faseb.org
 

Copyright (C) 2002 PR Newswire.